Fusco, Vittorio <br/><br/>
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  02 2017 
 - 345-349 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-016-3147-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bisphosphonate-Associated Osteonecrosis of the Jaw<br/>Bone Density Conservation Agents<br/>Denosumab<br/>Diphosphonates<br/>Humans<br/>Jaw Diseases<br/>Neoplasms<br/>Osteonecrosis